| PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine CK Cho, P Kang, CG Jang, SY Lee, YJ Lee, JW Bae, CI Choi Archives of Pharmacal Research, 1-24, 2024 | 1 | 2024 |
| Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism CK Cho, JY Mo, E Ko, P Kang, CG Jang, SY Lee, YJ Lee, JW Bae, CI Choi Archives of Pharmacal Research 47 (2), 95-110, 2024 | 1 | 2024 |
| PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes CK Cho, E Ko, JY Mo, P Kang, CG Jang, SY Lee, YJ Lee, JW Bae, CI Choi Archives of Pharmacal Research 47 (1), 82-94, 2024 | 2 | 2024 |
| Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes CK Cho, P Kang, CG Jang, SY Lee, YJ Lee, CI Choi Archives of Pharmacal Research 46 (11), 939-953, 2023 | 3 | 2023 |
| Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects P Kang, CK Cho, CG Jang, SY Lee, YJ Lee, CI Choi, JW Bae Archives of Pharmacal Research 46 (5), 438-447, 2023 | 5 | 2023 |
| Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects CK Cho, JY Byeon, P Kang, HJ Park, E Ko, CY Mu, CG Jang, SY Lee, ... Archives of Pharmacal Research 46 (2), 111-116, 2023 | 8 | 2023 |
| Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes CM Lee, P Kang, CK Cho, HJ Park, YJ Lee, JW Bae, CI Choi, HS Kim, ... Archives of Pharmacal Research 45 (6), 433-445, 2022 | 10 | 2022 |
| Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism CK Cho, P Kang, HJ Park, E Ko, CY Mu, YJ Lee, CI Choi, HS Kim, ... Archives of Pharmacal Research 45 (5), 352-366, 2022 | 15 | 2022 |
| Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects NT Kim, CK Cho, P Kang, HJ Park, YJ Lee, JW Bae, CG Jang, SY Lee Archives of Pharmacal Research 45 (2), 114-121, 2022 | 13 | 2022 |
| Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism YH Kim, P Kang, CK Cho, EH Jung, HJ Park, YJ Lee, JW Bae, CG Jang, ... Archives of Pharmacal Research 44, 713-724, 2021 | 25 | 2021 |
| Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes EH Jung, YJ Lee, DH Kim, P Kang, CW Lim, CK Cho, CG Jang, SY Lee, ... Archives of Pharmacal Research 43, 1356-1363, 2020 | 15 | 2020 |
| ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan HB Shin, EH Jung, P Kang, CW Lim, KY Oh, CK Cho, YJ Lee, CI Choi, ... Archives of Pharmacal Research 43, 1187-1196, 2020 | 22 | 2020 |
| Prediction of Flurbiprofen Pharmacokinetics by CYP2C9 Genotypes in Populations Utilizing a Physiological Based Pharmacokinetic Modeling HB Shin, CW Lim, KY Oh, CK Cho, EH Jung, CM Lee, JY Byeon, SY Lee The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| The Complete Chloroplast Genome of Pearl Millet (Pennisetum glaucum (L.) R. Br.) and Comparative Analysis within the Family Poaceae S Raveendar, GA Lee, KJ Lee, MJ Shin, JR Lee, SY Lee, GT Cho, KH Ma, ... Cereal Research Communications 47, 1-10, 2019 | 3 | 2019 |
| 2018 Korean society for the study of obesity guideline for the management of obesity in Korea MH Seo, WY Lee, SS Kim, JH Kang, JH Kang, KK Kim, BY Kim, YH Kim, ... Journal of obesity & metabolic syndrome 28 (1), 40, 2019 | 510 | 2019 |
| Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine JY Byeon, CM Lee, YJ Lee, YH Kim, SH Kim, EH Jung, WK Chae, YJ Lee, ... Archives of pharmacal research 42, 182-190, 2019 | 23 | 2019 |
| Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites HI Lee, JY Byeon, YH Kim, CM Lee, CI Choi, CG Jang, JW Bae, YJ Lee, ... European Journal of Clinical Pharmacology 74, 1417-1426, 2018 | 19 | 2018 |
| The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem JY Byeon, YH Kim, SH Kim, CM Lee, EH Jung, WK Chae, CG Jang, ... Archives of pharmacal research 41, 931-936, 2018 | 13 | 2018 |
| CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes JY Byeon, YH Kim, CM Lee, SH Kim, WK Chae, EH Jung, CI Choi, ... Archives of pharmacal research 41, 921-930, 2018 | 53 | 2018 |
| Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes SH Kim, JY Byeon, YH Kim, CM Lee, YJ Lee, CG Jang, SY Lee Scientific Reports 8 (1), 12405, 2018 | 26 | 2018 |
